Aardvark Therapeutics, Inc.
AARD$77M
Micro CapNASDAQPharmaceutical Preparations🇺🇸North AmericaSAN DIEGO33 employees
Drugs in Pipeline
2
Phase 3 Programs
1
Upcoming Catalysts
1
Next Catalyst
Mar 15, 2027
50wMarket Overview
Stock performance and key metrics
AARD News
Catalyst Timeline
1 upcoming, 2 past
Drug Pipeline
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
ARD-101 | Phase 3 | Hyperphagia | - | - |
Low Dose ARD-501 | Phase 2 | Autism Spectrum Disorder | - | - |
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply